SCHEDULE 13D/A

Aurinia Pharmaceuticals Inc

Common Shares, no par value · CUSIP: 05156V102

Event date: 2025-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621

  Shares: 10,029,500.00 · Class: 7.3%

• KEVIN TANGReported CIK 0001178579

  Shares: 10,029,500.00 · Class: 7.3%

• TANG CAPITAL PARTNERS, LPReported CIK 0001191935

  Shares: 5,140,591.00 · Class: 3.7%

• TANG CAPITAL PARTNERS INTERNATIONAL, LP

  Shares: 4,388,909.00 · Class: 3.2%

• TANG CAPITAL PARTNERS III, INC

  Shares: 500,000.00 · Class: 0.4%

• TANG CAPITAL PARTNERS IV, INC

  Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.